Additional file 1 of HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients

Additional file 1: Table S1. COVID-19 patient’s characteristics, FIMICS profiling, PBMCs. Recruited at PSD. Table S2. COVID-19 patient’s characteristics, technical validation, PBMCs. Recruited at PSD. Table S3. Odds ratio of lncRNAs related to death using logistic regression model (with and without age adjustment) and the AUC. Table S4. Transcripts annotation and primer sequences. Table S5. Univariate and multivariable analysis adjusted for age and sex with odds ratio of lncRNAs related to mortality and severity and the AUC. Table S6. COVID-19 patient’s characteristics, PBMCs. Recruited at MM.

附加文件1：
补充表S1：COVID-19患者临床特征、FIMICS分析谱、外周血单个核细胞（peripheral blood mononuclear cells, PBMCs），于PSD中心招募入组。
补充表S2：COVID-19患者临床特征、技术验证相关、外周血单个核细胞（PBMCs），于PSD中心招募入组。
补充表S3：采用逻辑回归模型（校正与未校正年龄）分析与死亡相关的长链非编码RNA（long non-coding RNAs, lncRNAs）的比值比及受试者工作特征曲线下面积（Area Under the Curve, AUC）。
补充表S4：转录本注释与引物序列。
补充表S5：校正年龄与性别的单变量及多变量分析，包含与死亡率和疾病严重程度相关的lncRNAs的比值比及AUC。
补充表S6：COVID-19患者临床特征、外周血单个核细胞（PBMCs），于MM中心招募入组。